Bayer Healthcare LLC v. Baxalta Inc. United States Court of Appeals of the Federal Circuit, 2021 989 F.3d 964

IF 0.2 4区生物学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Biotechnology Law Report Pub Date : 2021-06-01 DOI:10.1089/blr.2021.29229.cmh

引用次数: 0

查看原文本刊更多论文

拜耳医疗保健有限责任公司诉Baxalta公司案美国联邦巡回上诉法院，2021年989 F.3d 964

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Biotechnology Law Report 工程技术-生物工程与应用微生物

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： The leading authoritative journal since 1982 devoted to the evolving body of law and government regulation concerning biotechnology, particularly in the industries in which new products from these technologies are developing the most rapidly: pharmaceuticals, chemicals, agriculture, food processing, energy, mineral recovery, and waste treatment. All legal aspects are rapidly reported, and critical and often hard-to-obtain documents are reproduced.